Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127426 trials found · Page 566 of 6372
-
New hope for ovarian cancer: phase 3 trial tests targeted drug against Tough-to-Treat tumors
Disease control Recruiting nowThis is a clinical study that has three parts. It is testing a potential new medicine called Sofetabart Mipitecan (Sofe-M) for people with certain types of ovarian, peritoneal, and fallopian tube cancers. Part A enrolls participants with platinum-resistant cancer, meaning their d…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New heart pacing method tested against standard therapy in 850 patients
Disease control Recruiting nowThis study will compare two different methods to pace the heart to treat heart failure including: 1. The current standard method of implanting a pacing lead in a vein on the surface of the left lower chamber of the heart (left ventricle) to deliver heart failure therapy. This me…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New shot could let food allergy sufferers eat peanuts and milk safely
Disease control Recruiting nowPhase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy: This is a Phase 2b randomized, double-blind, placebo-controlled clinical trial evaluating RPT904, a next-generation anti-IgE monoclonal antibody, in people with food allergy. RPT904 is a long-…
Phase 2 • Sponsor: RAPT Therapeutics, Inc. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Engineered immune cells take on stomach cancer in new trial
Disease control Recruiting nowTo evaluate the efficacy of CT041 in sequential treatment after first-line treatment of advanced gastric/esophagogastric junction adenocarcinoma
Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New combo therapy aims to halt spread of aggressive breast cancer
Disease control Recruiting nowThis phase II trial tests how well radiation therapy with pembrolizumab and chemotherapy (paclitaxel or nab-paclitaxel or carboplatin and gemcitabine) works in treating patients with PD-L1 positive triple negative breast cancer that has spread from where it first started (primary…
Phase 2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New hope for rare sarcoma: targeted drug trial opens
Disease control Recruiting nowThis is a multi-center, open label, phase II study of tebentafusp in patients with unresectable or metastatic clear cell sarcoma (CCS).
Phase 2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New hope for Hard-to-Treat lobular breast cancer?
Disease control Recruiting nowTo learn if ivonescimab can help to control endocrine-refractory HR+ HER2- and/or TN mILC.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Brain-Saving bundle tested in 1,000 cardiac arrest patients
Disease control Recruiting nowThe investigators designed LAPTOPS to determine the effectiveness of a goal-directed neuroprotection bundles of active management including body temperature,PaCO2,PaO2,position,Blood glucose ,blood sodium,Blood pressure and Lactate vs. usual care in adult post-cardiac arrest care…
Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New PET scan probe could sharpen lung cancer detection
Diagnosis Recruiting nowThis study aims to investigate and evaluate the safety and performance of a novel probe, PFD3, for the diagnosis and assessment of patients with small cell lung cancer (SCLC).
Phase 1/2 • Sponsor: Peking University First Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Could a routine blood test spot many cancers early?
Diagnosis OngoingThis study aims to develop a pan-cancer screening model using routine blood biomarkers (including complete blood count, biochemical tests, coagulation panel, and tumor markers). The study is retrospective, collecting data from approximately 10,000,000 cancer patients diagnosed at…
Sponsor: Zhejiang Cancer Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
New hope for liver cancer: Triple-Drug cocktail enters Mid-Stage trial
Disease control Recruiting nowThe purpose of this study is to compare the effects on participants' and liver cancer by adding a drug that is used on its own to treat this disease to a combination of two other drugs which is also used to treat liver cancer, compared to the two-drug combination alone.
Phase 2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New hope: Chemo-Free cocktail targets advanced colorectal cancer
Disease control Recruiting nowColorectal cancer is a malignant tumor ranking among the top four in incidence and the top three in causes of death globally . Chemotherapy combined with anti-EGFR or anti-VEGF monoclonal antibodies is currently the standard first-line treatment for advanced pMMR colorectal cance…
Phase 2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New RSV vaccine LYB005 enters human trials for seniors
Vaccine OngoingThis is a randomized, observer-blinded, placebo-controlled Phase Ⅱ clinical trial to evaluate the immunogenicity and safety of the Respiratory Syncytial Virus (RSV) Vaccine, LYB005 in participants aged 60 years and older.
Phase 2 • Sponsor: Guangzhou Patronus Biotech Co., Ltd. • Aim: Vaccine
Last updated Jun 27, 2026 09:04 UTC
-
New hope for hard-to-treat cancers: targeted combo therapy enters trials
Disease control Recruiting nowThis is a Phase Ib/II clinical study aimed at exploring the safety and efficacy of Regimen A (GFH375 in combination with Cetuximab) and Regimen B (GFH375 in combination with AG) in participants with solid tumors.Phase Ib: To evaluate the safety/tolerability and pharmacokinetic (P…
Phase 1/2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New heart valve mimics nature to improve blood flow in major trial
Disease control Recruiting nowProspective, randomized, controlled, multicenter, international study. Up to 1054 subjects with a severe native calcific aortic stenosis who are determined by the local Heart Team to have an indication for Transcatheter Aortic Valve Replacement (TAVR), will be enrolled in the 'A…
Sponsor: Anteris Technologies Ltd. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Promising drug for rare balance disorder enters final testing phase
Disease control Recruiting nowSpinocerebellar ataxias 27B (SCA27B) is caused by an expansion of ≥ 250 GAA triplets in the FGF14 gene and accounts for 15% of cerebellar ataxias (around 500 patients in France). It is a late-onset form often presenting paroxysmal episodes of ataxia and/or diplopia. The disease p…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Brain gene therapy targets Parkinson's at its source
Disease control Recruiting nowParkinson's disease (PD) poses a severe threat to human health, and its incidence is rising year by year. Current therapeutic options are limited by significant shortcomings. Pathological aggregation of α-synuclein and the consequent death of dopaminergic neurons are the primary …
Phase 1 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:11 UTC
-
New stem cell combo could boost survival in blood cancer patients
Disease control Recruiting nowThis study aims to investigate the clinical efficacy of haploidentical-cord blood hematopoietic stem cell transplantation in patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS), and to analyze the impact of different engraftment patterns (hapl…
Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New hope for advanced colorectal cancer: drug cocktail shows promise
Disease control Recruiting nowThe aim of this study is to evaluate the activity of first-line trastuzumab-deruxtecan, capecitabine and bevacizumab in terms of overall response rate for patients with HER-2 positive metastatic/locally advanced unresectable colorectal cancer
Phase 2 • Sponsor: Gruppo Oncologico del Nord-Ovest • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
A patch, not a surgery: new device aims to monitor heart failure without implants
Diagnosis By invitation onlyThe purpose of the study is to examine the Vivio System's ability to track heart failure status in subjects, and compare the Vivio System's measurements to CardioMEMS measurements. Heart failure, which is a form of heart disease, is a condition where the heart does not pump enoug…
Sponsor: Ventric Health, LLC • Aim: Diagnosis
Last updated Jul 30, 2026 00:00 UTC